¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"shock proof"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
À̰ÍÀ» ¿øÇϼ̽À´Ï±î?
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • hypovolemic shock
    ÀúÇ÷·®¼îÅ©
  • heat shock
    ¿­¼îÅ©
  • heat shock response
    ¿­Ãæ°Ý¹ÝÀÀ
  • heat-shock protein
    ¿­Ãæ°Ý´Ü¹éÁú
  • hematogenic shock
    ÀúÇ÷·®¼îÅ©
  • hemorrhagic shock
    ÃâÇ÷¼îÅ©
  • irreversible shock
    ºñ°¡¿ª¼îÅ©
  • induced shock
    À¯µµ¼îÅ©
  • insulin shock
    Àν¶¸°¼îÅ©
  • neurogenic shock
    ½Å°æ¼º¼îÅ©
  • osmotic shock
    »ïÅõ¾ÐÃæ°Ý
  • postoperative shock
    ¼ö¼úÈļîÅ©
  • pain shock
    ÅëÁõ¼îÅ©
  • spinal shock
    ô¼ö¼îÅ©
  • streptococcal toxic shock syndrome
    »ç½½¾Ë±Õµ¶¼º¼îÅ©ÁõÈıº, ¿¬¼â±¸±Õµ¶¼º¼îÅ©ÁõÈıº
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • electric shock
    Àü±âÃæ°Ý
  • electric shock therapy
    Àü±âÃæ°Ý¿ä¹ý
  • endotoxin shock
    ³»µ¶¼Ò¼îÅ©
  • extracorporeal shock wave lithotripsy
    ¸ö¹ÛÃæ°ÝÆÄµ¹±þ¼ú, ü¿ÜÃæ°ÝÆÄ¼â¼®¼ú
  • gram negative shock
    ±×·¥À½¼º¼îÅ©
  • heat shock
    ¿­Ãæ°Ý
  • heat shock response
    ¿­Ãæ°Ý¹ÝÀÀ
  • heat-shock protein
    ¿­Ãæ°Ý´Ü¹é
  • hematogenic shock
    (¢¡hypovolemic shock) Ç÷¾×·®°¨¼Ò¼îÅ©
  • hemorrhagic shock
    ÃâÇ÷¼îÅ©
  • hyperglycemic shock
    °íÇ÷´ç¼îÅ©
  • hypoglycemic shock
    ÀúÇ÷´ç¼îÅ©, Àν¶¸°¼îÅ©
  • hypoglycemic shock therapy
    ÀúÇ÷´çÃæ°Ý¿ä¹ý, Àν¶¸°Ãæ°Ý¿ä¹ý
  • hypovolemic shock
    Ç÷¾×·®°¨¼Ò¼îÅ©
  • induced shock
    À¯µµ¼îÅ©
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 14 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • hemorrhage shock
    ÃâÇ÷¼º(õóúìàõ) ¼îÅ©
  • hemorrhagic shock
    ÃâÇ÷¼º¼ï
  • hyperglycemic shock
    °íÇ÷´ç¼º ¼ï.
  • hypovolemic shock
    (¼øÈ¯)Ç÷¾×·®°¨¼Ò¼º¼ï.
  • hypovolemic shock
    (¼øÈ¯)Ç÷¾×·®°¨¼Ò¼º¼ï
  • induced shock
    À¯µµ(ë¯Óô)¼ï.
  • induction shock
    À¯µµ¼ï.
  • insulin shock
    Àν¶¸°¼ï.
  • insulin shock therapy
    Àν¶¸°¼ï¿ä¹ý.
  • insulin shock treatment
    Àν¶¸°Ãæ°ÝÄ¡·á.
  • post electric shock syndrome
    Àü°Ý(ï³Ìª)¼ïÈÄÁõÈıº(¡­ý­ñøý¦ÏØ)
  • postelectric shock syndrome
    Àü°Ý¼ïÈÄÁõÈıº.
  • postoperative shock
    (¼ö)¼úÈļï.
  • postoperative shock
    (¼ö)¼úÈļï((â¢)âúý­¡­)
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • convulsive shock therapy
    °æ·ÃÃæ°Ý¿ä¹ý(ÌâÕýõú̪èþÛö).
  • convulsive shock therapy =CST
    °æ·Ã¼ï¿ä¹ý(¡­èþÛö).
  • counter shock
    ¿ªÃæ°Ý, Ä«¿îÅͼï.
  • culture shock
    ¹®È­Ãæ°Ý(Ùþûùõú̪)
  • diastolic shock
    È®Àå±â¼ï.
  • direct current shock
    Á÷·ùÀü°Ý¼ï.
  • direct current shock
    Á÷·ùÀü±Ø¼ï.
  • drug shock
    ¾à¹°Ãæ°Ý(¡­õú̪).
  • dye shock
    »ö¼ÒÃæ°Ý.
  • electric shock
    Àü±âÃæ°Ý
  • electric shock therapy(EST)
    Àü±âÃæ°Ý¿ä¹ý.
  • electric shock treatment
    Àü±âÃæ°ÝÄ¡·á.
  • endotoxic shock
    ³»µ¶¼Ò¼º ¼Ó
  • endotoxin shock
    ³»µ¶¼Ò¼ï
  • extracorporeal shock wave lithotripsy
    ü¿ÜÃæ°ÝÆÄ¼â¼®¼ú
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
ESWL Extracorporeal Shock-Wave Lithotripsy
  - Ix for Gall Stone
    ...
TSS Toxic Shock Syndrome
TSST-1 Toxic Shock Syndrome Toxin-1
  = Enterotoxin type F
CGS cardiogenic shock; catgut suture
CS calf serum; campomelic syndrome; carcinoid syndrome; cardiogenic shock; caries-susceptible; carotid ...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
DHF/DSS Dengue Haemorrhagic Fever/Dengue Shock Syndrome
DSS Dengue Shock Syndrome
ECS Electroconvulsive shock
ESWT Extracorporal Shock-Wave Therapy
HS Heat Shock
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 10 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • shock circuit reaction
    ´Ü¶ô ¹ÝÀÀ
    °¨Á¤Àû Ãæµ¿ÀÌ À̼ºÀÇ ÅëÁ¦¸¦ ¹þ¾î³ª Á÷Á¢À¸·Î Çൿ¿¡ ¿Å°ÜÁö´Â ¹ÝÀÀ.
  • shock kidney
    ¼îÅ©¼º ½Å ±â´É Àå¾Ö
    ¼îÅ©¿¡ ºüÁ® Ç÷¾Ð ÀúÇϰ¡ ±æ°Ô À̾îÁ® ½Å Ç÷·ù·®ÀÌ °¨¼ÒÇÏ¿© »ý±ä ±Þ¼º ½Å ºÎÀü.
  • shock lung
    ¼îÅ© Æó
    ÃâÇ÷¼º ¼îÅ© µî¿¡ ÇÕº´Çϴ ȣÈí ºÎÀü.
  • shock position
    ¼ï À§Ä¡
    ȯÀÚ°¡ ¼îÅ©¸¦ ÀÏÀ¸Ä×À» ¶§ ±× ±¸±Þ üÀ§·Î¼­ ÃëÇØÁö´Â üÀ§.
  • shock shortening heat
    ´ÜÃà ¿­
    ´ÜÃàÇÏ´Â ±æÀÌ¿¡ ºñ·ÊÇØ ºÎÇÏ¿¡ °ü°è¾øÀÌ ¹ß»ýÇÏ´Â ¿­.
  • shock term memory
    ´Ü±â ±â¾ï
  • shock treatment
    ¼ï Ä¡·á
    Ä«¸£µð¾ÆÁ¹ °æ·Ã ¿ä¹ý, Àü±â ¼îÅ© ¿ä¹ý, Àν¶¸° ¼îÅ© ¿ä¹ý µîÀÌ ÀÖ´Ù.
  • shock wave imaging
    Ãæ°ÝÆÄ »ó
  • state of shock
    Ãæ°Ý »óÅÂ
  • wound shock
    ¿Ü»ó¼º ¼ï
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
haemorrhagic shock Hypovolaemic shock resulting from acute haemorrhage, characterised by hypotension, tachycardia, pale, cold, and clammy skin, and oliguria.
(05 Mar 2000)
primary shock Shock mainly nervous in nature, from pain, anxiety, etc., which ensues almost immediately upon the receipt of a severe injury.
(05 Mar 2000)
heat-shock factor <cell biology, protein> A class of molecular chaperones found in both prokaryotes and in several compartments of eukaryotic cells. There is evidence that these proteins can interact with polypeptides during a variety of assembly processes in such a way as to prevent the formation of nonfunctional structures.
(12 Dec 1998)
Previous: heat-shock factor, heat-shock gene, heat-shock protein, heat-shock protein 27 kinaseNext: heat-shock proteins 90, heat-shock responseheat-shock factor -->heat-shock proteins 90
<cell biology, protein> A class of molecular chaperones whose members act in the mechanism of signal transduction by steroid receptors.
(12 Dec 1998)
heat-shock gene <molecular biology> A set of genes present in most animals which are transcribed suddenly, quickly, and with coordination when the animal is exposed to certain types of stress such as a sudden temperature increase.
(09 Oct 1997)
heat-shock protein <cell biology, molecular biology, protein> Families of proteins conserved through prokaryotic and eukaryotic cells and bacteria in response to hyperthermia and other environmental stresses, although some are constitutively expressed. They increase thermal tolerance and perform functions essential to cell survival under these conditions.
Some serve to stabilise proteins in abnormal configurations, play a role in folding and unfolding of proteins and the assembly of oligomeric complexes and may act as chaperonins. Hsp90 complexes with inactive steroid hormone receptor and is displaced upon ligand binding.
Four major sub classes are recognised: hsp90, hsp70, hsp60 and small hsps. Hsps have been suggested to act as major immunogens in many infections.
Acronym: HSP
(12 Dec 1998)
heat-shock protein 27 kinase <enzyme> Phosphorylates hsp 26 on serine residues when stimulated by tumour necrosis factor or interleukin 1
Registry number: EC 2.7.1.-
Synonym: hsp 27 kinase, heat-shock protein 27 kinase, hsp27 kinase
(26 Jun 1999)
heat-shock proteins 70 <cell biology, protein> A class of molecular chaperones found in both prokaryotes and in several compartments of eukaryotic cells. There is evidence that these proteins can interact with polypeptides during a variety of assembly processes in such a way as to prevent the formation of nonfunctional structures.
(12 Dec 1998)
heat-shock proteins 90 <cell biology, protein> A class of molecular chaperones whose members act in the mechanism of signal transduction by steroid receptors.
(12 Dec 1998)
heat-shock response <cell biology> A constellation of responses that occur when an organism is exposed to excessive heat and other environmental stresses. Responses include synthesis of some proteins, repression of other proteins, and expression of new proteins.
(12 Dec 1998)
heat-shock response element <cell biology, protein> The nucleotide sequence, CNNGAANNTCCNG, which is in the promoter region of the heat-shock genes. When the animal is exposed to certain types of stress such as a sudden rise in temperature, the first thing that happens to activate these genes is the binding of the HSE by a transcriptional enhancer protein.
(09 Oct 1997)
protein shock The systemic reaction following the parenteral administration of a protein.
(05 Mar 2000)
protein shock therapy The injection of a foreign protein to induce fever as a means of treating certain diseases.
Synonym: foreign protein therapy.
(05 Mar 2000)
pseudoanaphylactic shock A reaction that is similar to anaphylactic shock, but which does not require the incubation period characteristic of induced sensitivity (anaphylaxis); it is unrelated to antigen-antibody reactions.
Synonym: anaphylactoid crisis, pseudoanaphylactic shock.
(05 Mar 2000)
high-energy shock waves Compression waves of large amplitude, across which density, pressure, and particle velocity change drastically.
(12 Dec 1998)
histamine shock The shock state produced in animals by the injection of histamine; characterised by bronchiolar spasm in the guinea pig and constriction of hepatic veins in the dog.
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • shock dog
    »ð»ì°³
  • shock stall
    Ãæ°ÝÆÄ ½Ç¼Ó
  • shock therapy
    (Á¤½Åº´ÀÇ)Ãæ°Ý(Àü°Ý)¿ä¹ý
  • shock troops
    Ư°ø´ë
  • shock wave
    Ãæ°ÝÆÄ
  • proof
    Áõ¸í
  • ball proof
    ¹æÅºÀÇ
  • ball proof
    ¹æÅºÀÇ
  • cold-proof
    ³»ÇÑÀÇ
  • crush-proof
    Â¥ºÎ¶óÁöÁö ¾Ê´Â (Á¾ÀÌ »óÀÚµî)
  • decisive evidence proof
    °áÁ¤Àû Áõ°Å;È®Áõ
  • foul proof
    ±³Á¤À» º» ±³Á¤Áö
  • foundry proof
    Á¤ÆÇÀüÀÇ ÃÖÁ¾ ±³Á¤¼â
  • galley proof
    ±³Á¤¼â
  • gas proof
    °¡½º°¡ µé¾î°¡Áö ¾Ê´Â;³»°¡½º¼ºÀÇ
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á